Biocon Biologics
Mayank Garg is an experienced professional in the biopharmaceutical industry, currently serving as General Manager-MSAT and Sr. Director at Biocon Biologics since September 2020. Prior to this, Mayank held several key positions at Sanofi, including Team Lead for late-stage process development of cell culture-based biotherapeutics, and at Shantha Biotechnics, where responsibilities included leading modeling and process control strategies and project leadership for capacity expansion. Mayank's earlier roles included managerial positions at Dr. Reddy's Laboratories, Intas Biopharmaceuticals, and Biocon, focusing on manufacturing science, process development, and statistical analysis. Academic credentials include an M.Tech in Bioprocess Engineering from Jadavpur University and an MSc in Biotechnology from Chaudhary Charan Singh University.
This person is not in any teams
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics